It seems to me that rushing the timelines potentially opens up a lot of risks for post-vaccine side effects. Doesn't it?
It seems to me that rushing the timelines potentially opens up a lot of risks for post-vaccine side effects. Doesn't it?
[0] Even if shortcuts ... can be found, it is unlikely that a vaccine would be available earlier than 6 months after the initiation of clinical trials. Realistically, SARS-CoV-2 vaccines will not be available for another 12–18 months. From: https://www.cell.com/immunity/fulltext/S1074-7613(20)30120-5...
[1] https://www.cell.com/action/showFullTableHTML?isHtml=true&ta...
There is zero incentive to make a vaccine for the common cold. Let me introduce you to the multi-tens of billion dollar OTC common cold treatment market.
Depends what you mean by "need". If you're talking about a risk/benefit calculation for getting a vaccination, I expect it will play out very differently for high-risk elderly folks vs low-risk young adults.